USCDI+ Clinical Trials Matching Implementation Guide
0.1.0

⚠️ This is a developmental version of the guide and is under active development. Content may change at any time without notice. No official release has been made. The final base canonical URL and hosting location have not yet been determined. This guide should not be used for production implementations.

3.2.16. Medication-cancer-related-medication-admin-cyclophosphamide-jenny-m

{
"resourceType": "MedicationAdministration",
"id": "cancer-related-medication-admin-cyclophosphamide-jenny-m",
"meta": {
"profile": [
"http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration"
]
},
"text": {
"status": "extensions",
--- We have skipped the narrative for better readability of the resource ---
},
"extension": [
{
"url": "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent",
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "373808002",
"display": "Curative - procedure intent (qualifier value)"
}
]
}
}
],
"status": "completed",
"category": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/medicationrequest-category",
"code": "outpatient"
}
]
},
"medicationCodeableConcept": {
"coding": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"code": "3002",
"display": "cyclophosphamide"
}
]
},
"subject": {
"reference": "Patient/cancer-patient-jenny-m"
},
"effectiveDateTime": "2018-04-22",
"performer": [
{
"actor": {
"reference": "Practitioner/us-core-practitioner-nancy-oncology-nurse"
}
}
],
"reasonReference": [
{
"reference": "Condition/primary-cancer-condition-jenny-m"
}
],
"note": [
{
"authorReference": {
"reference": "Practitioner/us-core-practitioner-nancy-oncology-nurse"
},
"time": "2018-04-22",
"text": "cyclophosphamide (60 mg/m² IV), 932.59 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects."
}
],
"dosage": {
"route": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "47625008",
"display": "Intravenous route (qualifier value)"
}
]
},
"dose": {
"value": 932.59,
"unit": "mg",
"system": "http://unitsofmeasure.org",
"code": "mg"
}
}
}
<MedicationAdministration xmlns="http://hl7.org/fhir">
<id value="cancer-related-medication-admin-cyclophosphamide-jenny-m" />
<meta>
<profile value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration" />
</meta>
<text>
<status value="extensions" />
--- We have skipped the narrative for better readability of the resource ---
</text>
<extension url="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent">
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct" />
<code value="373808002" />
<display value="Curative - procedure intent (qualifier value)" />
</coding>
</valueCodeableConcept>
</extension>
<status value="completed" />
<category>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/medicationrequest-category" />
<code value="outpatient" />
</coding>
</category>
<medicationCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm" />
<code value="3002" />
<display value="cyclophosphamide" />
</coding>
</medicationCodeableConcept>
<subject>
<reference value="Patient/cancer-patient-jenny-m" />
</subject>
<effectiveDateTime value="2018-04-22" />
<performer>
<actor>
<reference value="Practitioner/us-core-practitioner-nancy-oncology-nurse" />
</actor>
</performer>
<reasonReference>
<reference value="Condition/primary-cancer-condition-jenny-m" />
</reasonReference>
<note>
<authorReference>
<reference value="Practitioner/us-core-practitioner-nancy-oncology-nurse" />
</authorReference>
<time value="2018-04-22" />
<text value="cyclophosphamide (60 mg/m² IV), 932.59 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects." />
</note>
<dosage>
<route>
<coding>
<system value="http://snomed.info/sct" />
<code value="47625008" />
<display value="Intravenous route (qualifier value)" />
</coding>
</route>
<dose>
<value value="932.59" />
<unit value="mg" />
<system value="http://unitsofmeasure.org" />
<code value="mg" />
</dose>
</dosage>
</MedicationAdministration>
MedicationAdministration
MedicationAdministration.id[0]cancer-related-medication-admin-cyclophosphamide-jenny-m
MedicationAdministration.meta[0].profile[0]http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration
MedicationAdministration.text[0].status[0]extensions
MedicationAdministration.text[0].div[0]<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: MedicationAdministration cancer-related-medication-admin-cyclophosphamide-jenny-m</b></p><a name="cancer-related-medication-admin-cyclophosphamide-jenny-m"> </a><a name="hccancer-related-medication-admin-cyclophosphamide-jenny-m"> </a><a name="cancer-related-medication-admin-cyclophosphamide-jenny-m-en-US"> </a><p><b>Procedure Intent Extension</b>: <span title="Codes:{http://snomed.info/sct 373808002}">Curative - procedure intent (qualifier value)</span></p><p><b>status</b>: Completed</p><p><b>category</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/medicationrequest-category outpatient}">Outpatient</span></p><p><b>medication</b>: <span title="Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 3002}">cyclophosphamide</span></p><p><b>subject</b>: <a href="Patient-cancer-patient-jenny-m.html">Jenny M Female, DoB: 1965-01-01 ( Medical Record Number: MRN1234 (use: usual, ))</a></p><p><b>effective</b>: 2018-04-22</p><h3>Performers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Actor</b></td></tr><tr><td style="display: none">*</td><td><a href="Practitioner-us-core-practitioner-nancy-oncology-nurse.html">Practitioner Nancy Nurse </a></td></tr></table><p><b>reasonReference</b>: <a href="Condition-primary-cancer-condition-jenny-m.html">Condition Primary malignant neoplasm of female left breast (disorder)</a></p><p><b>note</b>: cyclophosphamide (60 mg/m² IV), 932.59 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/us-core-practitioner-nancy-oncology-nurse @2018-04-22)</p><h3>Dosages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://snomed.info/sct 47625008}">Intravenous route (qualifier value)</span></td><td>932.59 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM codemg = 'mg')</span></td></tr></table></div>
MedicationAdministration.extension[0].url[0]http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent
MedicationAdministration.extension[0].value[0].coding[0].system[0]http://snomed.info/sct
MedicationAdministration.extension[0].value[0].coding[0].code[0]373808002
MedicationAdministration.extension[0].value[0].coding[0].display[0]Curative - procedure intent (qualifier value)
MedicationAdministration.status[0]completed
MedicationAdministration.category[0].coding[0].system[0]http://terminology.hl7.org/CodeSystem/medicationrequest-category
MedicationAdministration.category[0].coding[0].code[0]outpatient
MedicationAdministration.medication[0].coding[0].system[0]http://www.nlm.nih.gov/research/umls/rxnorm
MedicationAdministration.medication[0].coding[0].code[0]3002
MedicationAdministration.medication[0].coding[0].display[0]cyclophosphamide
MedicationAdministration.subject[0].reference[0]Patient/cancer-patient-jenny-m
MedicationAdministration.effective[0]2018-04-22
MedicationAdministration.performer[0].actor[0].reference[0]Practitioner/us-core-practitioner-nancy-oncology-nurse
MedicationAdministration.reasonReference[0].reference[0]Condition/primary-cancer-condition-jenny-m
MedicationAdministration.note[0].author[0].reference[0]Practitioner/us-core-practitioner-nancy-oncology-nurse
MedicationAdministration.note[0].time[0]2018-04-22
MedicationAdministration.note[0].text[0]cyclophosphamide (60 mg/m² IV), 932.59 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects.
MedicationAdministration.dosage[0].route[0].coding[0].system[0]http://snomed.info/sct
MedicationAdministration.dosage[0].route[0].coding[0].code[0]47625008
MedicationAdministration.dosage[0].route[0].coding[0].display[0]Intravenous route (qualifier value)
MedicationAdministration.dosage[0].dose[0].value[0]932.59
MedicationAdministration.dosage[0].dose[0].unit[0]mg
MedicationAdministration.dosage[0].dose[0].system[0]http://unitsofmeasure.org
MedicationAdministration.dosage[0].dose[0].code[0]mg